Your search returned 7 results.

Results
	1.	A safety evaluation of brentuximab vedotin for the treatment of Hodgkin lymphoma. [electronic resource] by Oak, Eunhye Bartlett, Nancy L Producer: 20170130 In: Expert opinion on drug safety vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Blinatumomab for the treatment of B-cell lymphoma. [electronic resource] by Oak, Eunhye Bartlett, Nancy L Producer: 20160101 In: Expert opinion on investigational drugs vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Maintenance rituximab every 2 months is more toxic than every 3 months in patients with non-Hodgkin lymphoma. [electronic resource] by Rashidi, Armin Oak, Eunhye Bartlett, Nancy L Producer: 20150728 In: Blood vol. 125 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Outcomes with R-CEOP for R-CHOP-ineligible patients with diffuse large B-cell lymphoma are highly dependent on cell of origin defined by Hans criteria. [electronic resource] by Rashidi, Armin Oak, Eunhye Carson, Kenneth R Wagner-Johnston, Nina D Kreisel, Friederike Bartlett, Nancy L Producer: 20170106 In: Leukemia & lymphoma vol. 57 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Minimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I study. [electronic resource] by Goyal, Sagun Oak, Eunhye Luo, Jingqin Cashen, Amanda F Carson, Kenneth Fehniger, Todd DiPersio, John Bartlett, Nancy L Wagner-Johnston, Nina D Producer: 20180731 In: Leukemia & lymphoma vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma-a "real world" study. [electronic resource] by Epperla, Narendranath Hamadani, Mehdi Cashen, Amanda F Ahn, Kwang W Oak, Eunhye Kanate, Abraham S Calzada, Oscar Cohen, Jonathon B Farmer, Luke Ghosh, Nilanjan Tallarico, Michael Nabhan, Chadi Costa, Luciano J Kenkre, Vaishalee P Hari, Parameswaran N Fenske, Timothy S Producer: 20180104 In: Hematological oncology vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	De novo CD5+ diffuse large B-cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort. [electronic resource] by Alinari, Lapo Gru, Alejandro Quinion, Carl Huang, Ying Lozanski, Arletta Lozanski, Gerard Poston, Jacqueline Venkataraman, Girish Oak, Eunhye Kreisel, Friederike Park, Steven I Matthews, Stephanie Abramson, Jeremy S Iris Lim, Hana Martin, Peter Cohen, Jonathon B Evens, Andrew Al-Mansour, Zeina Singavi, Arun Fenske, Timothy S Blum, Kristie A Producer: 20160803 In: American journal of hematology vol. 91 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)